In contrast, Taspinar et al and Hishida et al claimed that GSTM1 polymorphism was not associated with the risk of CML, which was in agreement with our study (Hishida et al., 2005; Taspinar et al., 2008). Here, GSTM1 is linked to chronic myelogenous leukemia, BCR-ABL1 positive.